Article

Differential role of cholecystokinin receptor subtypes in opioid modulation of ongoing maternal behavior

University of São Paulo, San Paulo, São Paulo, Brazil
Pharmacology Biochemistry and Behavior (Impact Factor: 2.82). 10/1999; 64(1):165-9. DOI: 10.1016/S0091-3057(99)00117-3
Source: PubMed

ABSTRACT Cholecystokinin (CCK) can have effects opposite those of opioids. The present study was undertaken to determine whether peripheral injections of antagonists of the CCK1 receptor (lorglumide) and the CCK2 receptor (L-365,260) can influence the effects of morphine on maternal behavior during lactation. A total of 110 female Wistar rats were tested on days 5 and 6 postpartum. Groups were randomly assigned to morphine vehicle (MV-SC) + saline (S-IP), MV + lorglumide (LOR: 1.0 or 10.0 mg/kg), MV + L-365,260 (10 mg/kg), morphine chlorhydrate (MC: 7.0 mg/kg) + S, MC + LOR (1.0 or 10.0 mg/kg), and MC + L-365,260 (1.0 or 10 mg/kg). Maternal behavior testing was started 30 min after the injections, at which time pups were placed in the home cage of their mother. Latencies for retrieval, grouping, and crouching responses were scored. The results show that both lorglumide and L-365,260 potentiated the MC-induced inhibition of maternal behavior. In addition L-365,260 treatment alone inhibited maternal behavior. Blockade of both the CCK1 and CCK2 receptors potentiated the morphine-induced disruption of maternal behavior, while CCK2 antagonism alone also inhibited this behavior. The results suggest that CCK antagonism of opioid-induced disruption of maternal behavior occurs due to the action of CCK on both CCK1 and CCK2 receptor subtypes.

0 Followers
 · 
67 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: In rodents ongoing maternal behaviour requires activation of dopamine receptors. Therefore, it is possible that some motor components of maternal behaviour might be mediated by concurrent dopaminergic stimulation. It has been previously demonstrated that peripheral injections of some antipsychotic drugs such as pimozide have disruptive effects on maternal behaviour. The present experiments were designed to verify the effects of pharmacological blockade of limbic dopamine receptors on ongoing maternal behaviour in lactating rats. The hypothesis that central injections of the drug pimozide would have an effect on maternal behaviour was tested. We investigated the effects of central bilateral intra-accumbens microinjections of the dopamine D2 receptor antagonist pimozide (1.5 and 3.0 microg) on maternal behaviour. Animals treated with 3.0 microg of pimozide showed significantly longer latencies for all parameters of maternal behaviour compared to controls. These results suggest that dopamine receptors in the nucleus accumbens play a role in ongoing maternal behaviour.
    Pharmacology &amp Toxicology 08/2003; 93(1):42-7. DOI:10.1034/j.1600-0773.2003.930106.x
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: This paper is the twenty-first installment of our annual review of research concerning the opiate system. It summarizes papers published during 1998 that studied the behavioral effects of the opiate peptides and antagonists, excluding the purely analgesic effects, although stress-induced analgesia is included. The specific topics covered this year include stress; tolerance and dependence; eating and drinking; alcohol; gastrointestinal, renal, and hepatic function; mental illness and mood; learning, memory, and reward; cardiovascular responses; respiration and thermoregulation; seizures and other neurologic disorders; electrical-related activity; general activity and locomotion; sex, pregnancy, and development; immunologic responses; and other behaviors.
    Peptides 01/2000; 20(12):1527-74. DOI:10.1016/S0196-9781(99)00166-7 · 2.61 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Stereotyped behavior is elicited by activation of dopaminergic systems with drugs such as apomorphine and amphetamine. In previous studies, we have reported that the sulfated cholecystokinin octapeptide (CCK-8) decreased apomorphine-induced stereotypy in animals with normal and supersensitive dopamine receptors. The aim of the present study was to evaluate the effects of CCK(1) and CCK(2) receptor antagonists on stereotyped behavior induced by apomorphine or amphetamine. Rats were pretreated with the CCK(1) (SR 27897B; 1-[[2-(4-(2-chlorophenyl) thiazol-2-yl) aminocarbonyl]indolyl]acetic acid; 500 microg/kg; i.p.) or CCK(2) (L-365,260; 3R-(+)-N-(2,3-dihydro-1-methyl-2-oxo-5 phenyl-1H-1, 4-benzodiazepine-3-yl)-N'-(3-methyl phenyl)-urea; 500 microg/kg; i.p. ) receptor antagonists or saline 15 min before apomorphine (0.6 mg/kg; s.c.) or amphetamine (9.0 mg/kg; i.p.) injection. Both CCK(1) and CCK(2) receptor antagonists significantly increased apomorphine-induced stereotypy. In contrast, only the blockade of CCK(2) receptors significantly decreased amphetamine-induced stereotypy. The results suggest a dual opposite mechanism for CCK-dopamine interactions. These data also suggest that both apomorphine- and amphetamine-induced stereotypy should be used whenever effects of drugs acting on dopaminergic systems are being assessed.
    European Journal of Pharmacology 02/2000; 387(2):189-96. DOI:10.1016/S0014-2999(99)00782-7 · 2.68 Impact Factor